Berkshire Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,800
Closed -$86.4K 224
2023
Q2
$86.4K Hold
10,800
0.01% 228
2023
Q1
$87.5K Hold
10,800
0.01% 228
2022
Q4
$67.8K Sell
10,800
-1,100
-9% -$7.68K ﹤0.01% 139
2022
Q3
$82K Hold
11,900
0.01% 218
2022
Q2
$99K Buy
+11,900
New +$166K 0.01% 221

Other funds holding BHC

Berkshire Asset Management's BHC Position: Q3 2023 in Review

Berkshire Asset Management sold out of Bausch Health (BHC) in Q3 2023, closing a stake of 10,800 shares — an estimated $86.4K sold.

Berkshire Asset Management first reported a position in BHC in Q2 2022 and held it in 5 quarters. The position peaked at $99K in Q2 2022. 223 funds tracked by Wall St. Rank hold BHC as of Q3 2023.

  • Berkshire Asset Management reported no remaining Bausch Health position as of Q3 2023 after selling out during the quarter.
  • Berkshire Asset Management sold 10,800 Bausch Health shares in Q3 2023, an estimated $86.4K.
  • Berkshire Asset Management first reported a position in Bausch Health in Q2 2022 and held it in 5 quarters.
  • Berkshire Asset Management's Bausch Health position peaked at $99K in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Bausch Health as of Q3 2023.

Based on Berkshire Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.